Statistical Analysis Plan
Year: 2019
Type: article
Abstract: Statistical analysis plan for the MTBVAC 201 clinical trial. A phase Ib, randomised, double-blind, dose-escalation clinical trial of the safety, reactogenicity and immunogenicity of MTBVAC compared to BCG Vaccine SSI, in newborns living in a tuberculosis endemic region with a safety arm in adults.
Source: Figshare
DOI: 10.25375/uct.7970177
Authors: Tameris, Michele, Mearns, Helen, Penn-Nicholson, Adam, Gregg, Yolande, Bilek, Nicole, Mabwe, Simbarashe, Geldenhuys, Hennie, Shenje, Justine, Luabeya, Angelique, Murillo, Ingrid, Doce, Juana, Aguilo, Nacho, Marinova, Dessislava, Rodriguez, Esteban, Pentes, Eugenia, Gonzalo-Asensio, Jesús, Fritzell, Bernard, Thole, Jelle, Martin, Carlos, Scriba, Thomas, Hatherill, Mark, Team, MTBVAC Clinical Trial
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6945219394
FWCI:
Cites:
Cited by:
Related to: